Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endocrine Disruptors and Gynecological Malignancies.

Diagnostics (Basel, Switzerland)·2026

Same author

The Follicular Immune Checkpoint: PD-1/PD-L1 and Immune Tolerance in Oocyte Competence and IVF Failure.

International journal of molecular sciences·2026

Same author

Implementation Structure of ERAS Components in Gynecologic Oncology During Early Adoption: A Network-Based Analysis.

Journal of clinical medicine·2026

Same author

Lymphovascular space involvement as a prognostic factor for survival outcomes in vulvar cancer: A systematic review and meta-analysis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026

Same author

Endometrial Microbiome Profiles in Women Evaluated for Infertility or Recurrent Miscarriage: A Single-Center Descriptive Study.

Diagnostics (Basel, Switzerland)·2026

Same author

The Role of Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Metastases from Breast Cancer: A Comprehensive Review and Pooled Individual-Patient Analysis.

Journal of clinical medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

The Impact of Positive Peritoneal Cytology on the Survival Rates of Early-Stage-Disease Endometrial Cancer Patients:

Vasilios Pergialiotis¹, Michail Panagiotopoulos¹, Antonios Koutras¹

¹First Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, "Alexandra" General Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.

Medicina (Kaunas, Lithuania)

|May 25, 2024

Summary

Positive peritoneal cytology in early-stage endometrial cancer is a negative prognostic indicator, significantly reducing recurrence-free and overall survival. Further research is needed to determine its inclusion in future staging systems.

Keywords:

endometrial cancer meta-analysis overall survival peritoneal cytology recurrence-free survival

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

Related Experiment Videos

Last Updated: Jun 15, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

Area of Science:

Gynecologic Oncology
Cancer Staging
Clinical Prognostics

Background:

The prognostic significance of positive peritoneal cytology in early-stage endometrial cancer remains controversial.
Current staging systems do not incorporate peritoneal cytology findings.
Emerging evidence suggests a potential negative impact on patient survival outcomes.

Approach:

A systematic review and meta-analysis of relevant studies was conducted.
Databases searched included Medline, Scopus, CENTRAL, Google Scholar, and Clinicaltrials.gov.
Methodological quality was assessed using the Newcastle-Ottawa scale, with sensitivity and trial sequential analyses performed.

Key Points:

The meta-analysis included 15 articles involving 19,255 women with early-stage endometrial cancer.
Positive peritoneal cytology was associated with significantly lower 5-year recurrence-free survival (HR 0.26).
Patients with positive peritoneal cytology also showed reduced 5-year overall survival (HR 0.50).

Conclusions:

Positive peritoneal cytology appears to be a negative prognostic indicator in endometrial cancer.
The findings suggest a need to re-evaluate the role of peritoneal cytology in cancer staging.
Further research incorporating molecular profiling is recommended for future staging system considerations.